Merit Cudkowicz, MD
Massachusetts General Hospital · Professor of Neurology of the Harvard Medical School · Associate Professor of Neurology, Harvard Medical School, Massachusetts General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Merit Cudkowicz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:29 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07410806 · HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD · active not recruiting · Amyotrophic Lateral Sclerosis (ALS) · principal investigator
- Ph2/Ph3NCT05842941 · HEALEY ALS Platform Trial - Regimen G DNL343Merit E. Cudkowicz, MD · completed · Amyotrophic Lateral Sclerosis · principal investigator
- Ph2/Ph3NCT05740813 · HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262Merit E. Cudkowicz, MD · completed · Amyotrophic Lateral Sclerosis · principal investigator
- Ph2/Ph3NCT05136885 · HEALEY ALS Platform Trial - Regimen E SLS-005 - TrehaloseMerit E. Cudkowicz, MD · completed · Amyotrophic Lateral Sclerosis · principal investigator
- Ph2/Ph3NCT04615923 · HEALEY ALS Platform Trial - Regimen D PridopidineMerit E. Cudkowicz, MD · completed · Amyotrophic Lateral Sclerosis · principal investigator
- Ph2/Ph3NCT04436510 · HEALEY ALS Platform Trial - Regimen B VerdiperstatMerit E. Cudkowicz, MD · completed · Amyotrophic Lateral Sclerosis · principal investigator
- Ph2/Ph3NCT04297683 · HEALEY ALS Platform Trial - Master ProtocolMerit E. Cudkowicz, MD · active not recruiting · Amyotrophic Lateral Sclerosis · principal investigator
- Ph2NCT02017912 · Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALSBrainstorm-Cell Therapeutics · completed · Amyotrophic Lateral Sclerosis (ALS) · principal investigator
- Ph2NCT01854294 · GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)Genervon Biopharmaceuticals, LLC · completed · Amyotrophic Lateral Sclerosis · principal investigator
- Ph3NCT01281189 · Phase 3 Study of Dexpramipexole in ALSKnopp Biosciences · completed · Amyotrophic Lateral Sclerosis · principal investigator
- Ph1NCT01041222 · Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene MutationsIonis Pharmaceuticals, Inc. · completed · Familial Amyotrophic Lateral Sclerosis · study chair
- Ph2/Ph3NCT00818389 · Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)Massachusetts General Hospital · terminated · Amyotrophic Lateral Sclerosis · principal investigator
- Ph2/Ph3NCT00706147 · Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral SclerosisUniversity of Miami · completed · Amyotrophic Lateral Sclerosis · principal investigator
- Ph3NCT00608881 · Coenzyme Q10 in Huntington's Disease (HD)Massachusetts General Hospital · terminated · Huntington's Disease · principal investigator
- Ph2NCT00561366 · A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALSCytRx · withdrawn · Amyotrophic Lateral Sclerosis · principal investigator
- Ph3NCT00349622 · Clinical Trial Ceftriaxone in Subjects With ALSMassachusetts General Hospital · completed · Amyotrophic Lateral Sclerosis, ALS · principal investigator
- Ph2NCT00244244 · A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALSCytRx · completed · Amyotrophic Lateral Sclerosis (ALS) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Clinical Trial of Ceftriaxone in Subjects with ALSU01NS049640 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Merit E CUDKOWICZ · fiscal years 2006 to 2012Named on NCT00818389, NCT00349622
- Coenzyme Q10 in Huntingtons DiseaseU01NS052592 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Merit E CUDKOWICZ · fiscal years 2008 to 2013Named on NCT00608881
- Coordination and Statistics for Coenzyme Q10 in Huntington's DiseaseR01NS052619 · NINDS · UNIVERSITY OF ROCHESTER · PI Michael P McDermott · fiscal years 2005 to 2014Named on NCT00608881
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.